@NP	Xenotransplantation of transgenic pig olfactory ensheathing cells	1
@NP	Xenotransplantation	1
@NP	transgenic pig olfactory ensheathing cells	24
@NP	axonal regeneration	76
@NP	rat spinal cord	99
@NP	Abstract	116
@NP	we	130
@NP	transplantation of olfactory ensheathing cells	142
@NP	transplantation	142
@NP	olfactory ensheathing cells	161
@NP	OECs	190
@NP	Schwann cells	199
@NP	transgenic pigs	226
@NP	the human complement inhibitory protein , CD59 -LRB- hCD59 -RRB-	253
@NP	the human complement inhibitory protein	253
@NP	CD59	294
@NP	hCD59	300
@NP	dorsal column lesions of the spinal cord of the immunosuppressed rat	324
@NP	dorsal column lesions	324
@NP	the spinal cord of the immunosuppressed rat	349
@NP	the spinal cord	349
@NP	the immunosuppressed rat	368
@NP	axonal regeneration	403
@NP	Non-transplanted lesion-controlled rats	424
@NP	no impulse conduction	474
@NP	the transection site	503
@NP	animals	536
@NP	transgenic pig OECs or Schwann cells	554
@NP	impulse conduction	591
@NP	the lesion site	641
@NP	more than a centimeter	661
@NP	Cell labeling	685
@NP	the donor cells	714
@NP	the denervated host tract	744
@NP	the	744
@NP	host tract	759
@NP	Conduction velocity measurements	771
@NP	the regenerated axons	816
@NP	impulses	848
@NP	normal axons	869
@NP	morphological analysis	886
@NP	the axons	910
@NP	a peripheral pattern of myelin expected from the donor cell type	951
@NP	a peripheral pattern	951
@NP	myelin expected from the donor cell type	975
@NP	myelin	975
@NP	the donor cell type	996
@NP	These results	1017
@NP	xenotranplantation	1045
@NP	myelin-forming cells	1067
@NP	pigs genetically altered to reduce the hyperacute response in humans	1093
@NP	pigs	1093
@NP	the hyperacute response	1128
@NP	humans	1155
@NP	elongative axonal regeneration and remyelination	1181
@NP	impulse conduction	1242
@NP	the transected spinal cord	1268
@NP	There	1297
@NP	much interest	1306
@NP	the potential	1323
@NP	xenotransplantation	1340
@NP	genetically engineered pig cells as a source for human cell therapies1 ,2	1363
@NP	genetically engineered pig cells	1363
@NP	a source for human cell therapies1 ,2	1399
@NP	a source	1399
@NP	human cell therapies1 ,2	1412
@NP	human cell therapies1	1412
@NP	,2	1433
@NP	primate tissues	1444
@NP	pigs	1461
@NP	an ethically acceptable source of cells	1493
@NP	an ethically acceptable source	1493
@NP	cells	1527
@NP	relatively large quantities of pig cells	1544
@NP	relatively large quantities	1544
@NP	pig cells	1575
@NP	potential cell therapies	1606
@NP	An important obstacle with xenotranplantation	1632
@NP	An important obstacle	1632
@NP	xenotranplantation	1659
@NP	the problem	1681
@NP	natural antibody reactivity and subsequent complement activation	1696
@NP	complement-mediated cell lysis	1775
@NP	One approach to address this problem	1807
@NP	One approach	1807
@NP	this problem	1831
@NP	engineer pig cells	1856
@NP	a human complement inhibitory protein -LRB- e.g. , hCD59 -RRB-	1886
@NP	a human complement inhibitory protein	1886
@NP	e.g. , hCD59	1925
@NP	e.g.	1925
@NP	hCD59	1931
@NP	the present study	1942
@NP	we	1960
@NP	transgenic pigs engineered to express hCD59	1980
@NP	transgenic pigs	1980
@NP	hCD59	2018
@NP	this protein	2042
@NP	olfactory ensheathing cells -LRB- OECs -RRB- and Schwann cells	2058
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	2058
@NP	olfactory ensheathing cells	2058
@NP	OECs	2087
@NP	Schwann cells	2097
@NP	these cells	2121
@NP	the transected rat spinal cord	2155
@NP	they	2187
@NP	axonal regeneration	2203
@NP	new	2229
@NP	conduction	2252
@NP	the injured spinal cord	2266
@NP	rat models	2294
@NP	transplants	2306
@NP	OECs	2330
@NP	ablated corticospinal tract3 , fasciculus gracilis4 , or nerve bridges	2340
@NP	ablated corticospinal tract3	2340
@NP	fasciculus gracilis4	2370
@NP	nerve bridges	2395
@NP	the spinal cord5	2412
@NP	axonal regeneration	2437
@NP	OECs	2458
@NP	several unique properties	2468
@NP	a rationale for their potential	2507
@NP	a rationale	2507
@NP	their potential	2523
@NP	CNS axonal regeneration	2550
@NP	OECs	2575
@NP	specialized cells	2584
@NP	axons	2615
@NP	the olfactory epithelium and project	2632
@NP	the peripheral nervous system	2677
@NP	the olfactory bulb of the central nervous system	2712
@NP	the olfactory bulb	2712
@NP	the central nervous system	2734
@NP	they	2762
@NP	pluripotential cells	2771
@NP	Schwann cell or astrocyte-like cell properties6	2806
@NP	Schwann cell	2806
@NP	astrocyte-like cell properties6	2822
@NP	The possibility	2855
@NP	OECs or Schwann cells , which also support CNS regeneration4 ,7 ,	2876
@NP	OECs or Schwann cells	2876
@NP	CNS regeneration4 ,7	2918
@NP	a cell therapy in humans	2956
@NP	a cell therapy	2956
@NP	humans	2974
@NP	the transected3 -- 5 and demyelinated8 ,9 spinal cord	2991
@NP	the transected3	2991
@NP	5 and demyelinated8 ,9 spinal cord	3007
@NP	5 and demyelinated8	3007
@NP	,9 spinal cord	3026
@NP	enough of the appropriate cells	3077
@NP	enough	3077
@NP	the appropriate cells	3087
@NP	Our results	3131
@NP	these genetically altered pig cells	3157
@NP	elongative regeneration of electrophysiologically functional axons	3218
@NP	elongative regeneration	3218
@NP	electrophysiologically functional axons	3245
@NP	a site of spinal cord transection in the immunosuppressed rat	3292
@NP	a site	3292
@NP	spinal cord transection in the immunosuppressed rat	3302
@NP	spinal cord transection	3302
@NP	the immunosuppressed rat	3329
@NP	These findings	3355
@NP	important prerequisites	3374
@NP	consideration	3402
@NP	these cells as candidates for xenotransplantation studies in humans	3419
@NP	these cells	3419
@NP	candidates for xenotransplantation studies in humans	3434
@NP	candidates	3434
@NP	xenotransplantation studies in humans	3449
@NP	xenotransplantation studies	3449
@NP	humans	3480
@NP	Results Figure 1 .	3489
@NP	Results	3489
@NP	Figure 1	3498
@NP	FACS analysis	3508
@NP	transgenic Schwann cells	3525
@NP	transgenic olfactory ensheathing cells -LRB- OECs -RRB-	3554
@NP	transgenic olfactory ensheathing cells	3554
@NP	OECs	3594
@NP	CD59	3611
@NP	SLA class I -LRB- A and B -RRB-	3617
@NP	SLA class I	3617
@NP	A and B	3630
@NP	A	3630
@NP	B	3636
@NP	the mAb PT85A and the goat antimouse	3657
@NP	the mAb PT85A	3657
@NP	the goat antimouse	3675
@NP	secondary control	3694
@NP	background reactivity of a non-specific antibody	3734
@NP	background reactivity	3734
@NP	a non-specific antibody	3759
@NP	CD59	3784
@NP	mAb MEM43 -LRB- A and B -RRB- and the polyclonal Ab ALP3 -LRB- C and D -RRB-	3807
@NP	mAb MEM43	3807
@NP	A and B	3818
@NP	A	3818
@NP	B	3824
@NP	the polyclonal Ab ALP3	3831
@NP	C and D	3855
@NP	C	3855
@NP	D	3861
@NP	Cells	3865
@NP	a Becton-Dickinson FACSort	3888
@NP	Figure 2 .	3917
@NP	Figure	3917
@NP	2	3924
@NP	Conduction across the transplantation zone .	3927
@NP	Conduction	3927
@NP	the transplantation zone	3945
@NP	-LRB- A -RRB- Schematic	3971
@NP	-LRB- A -RRB-	3971
@NP	Schematic	3975
@NP	transection site and positions of stimulating and recording electrodes	3993
@NP	transection site and positions	3993
@NP	electrodes	4053
@NP	Stimulating electrodes	4065
@NP	1 mm caudal	4104
@NP	the dorsal column transection site -LRB- 0 mm -RRB-	4119
@NP	the dorsal column transection site	4119
@NP	0 mm	4155
@NP	recordings	4165
@NP	1 mm intervals	4193
@NP	the lesion site	4215
@NP	-LRB- B -RRB- CAP recordings for control lesion	4232
@NP	-LRB- B -RRB- CAP recordings	4232
@NP	-LRB- B -RRB-	4232
@NP	control lesion	4255
@NP	2 -LRB- R1 -RRB- and 3 -LRB- R2 -RRB-	4279
@NP	2 -LRB- R1 -RRB-	4279
@NP	3 -LRB- R2 -RRB-	4290
@NP	mm rostral	4297
@NP	the stimulating site	4311
@NP	i.e. , 1 and 2 mm beyond the transection site , respectively	4333
@NP	i.e.	4333
@NP	1	4339
@NP	2 mm beyond the transection site , respectively	4345
@NP	2 mm	4345
@NP	the transection site , respectively	4357
@NP	the transection site	4357
@NP	lesioned dorsal columns without cell transplantation	4396
@NP	lesioned dorsal columns	4396
@NP	cell transplantation	4428
@NP	Field potential recording	4454
@NP	dorsal column lesion of OEC transplant recipient	4492
@NP	dorsal column lesion	4492
@NP	OEC transplant recipient	4516
@NP	OEC transplant	4516
@NP	The peak negativities	4542
@NP	solid squares	4581
@NP	Figure 3 .	4597
@NP	Figure	4597
@NP	3	4604
@NP	Conduction properties of transplant-induced	4607
@NP	Conduction properties	4607
@NP	transplant-induced	4632
@NP	spinal cord axons	4663
@NP	-LRB- A -RRB-	4682
@NP	Comparison	4686
@NP	conduction velocity	4700
@NP	normal -LRB- non-lesioned -RRB- , dorsal column transection alone	4728
@NP	normal -LRB- non-lesioned -RRB- , dorsal column transection	4728
@NP	normal	4728
@NP	dorsal column transection	4751
@NP	Cont .	4784
@NP	transplantation of transgenic OECs or Schwann cells	4817
@NP	transplantation	4817
@NP	transgenic OECs or Schwann cells	4836
@NP	-LRB- B -RRB-	4870
@NP	no impulse conduction	4883
@NP	dorsal columns without cell transplantation , both OEC - and Schwann	4933
@NP	dorsal columns without cell transplantation , both OEC	4933
@NP	dorsal columns	4933
@NP	cell transplantation , both	4956
@NP	cell transplantation	4956
@NP	Schwann	4992
@NP	cells-transplant groups	5000
@NP	conduction	5034
@NP	the lesion	5052
@NP	distances comparable to controls	5067
@NP	distances	5067
@NP	controls	5091
@NP	-LRB- C -RRB- Both OEC	5101
@NP	-LRB- C -RRB-	5101
@NP	OEC	5110
@NP	Schwan cell-transplant groups	5119
@NP	high frequency stimulation similarly to non-lesioned controls	5159
@NP	high frequency stimulation	5159
@NP	non-lesioned controls	5199
@NP	-LRB- D -RRB- The refractory period from paired pulse stimulation experiments	5222
@NP	-LRB- D -RRB-	5222
@NP	The refractory period	5226
@NP	paired pulse stimulation experiments	5253
@NP	control and transplant groups	5310
@NP	Figure 4 .	5342
@NP	Figure	5342
@NP	4	5349
@NP	Presence of transgenic pig donor OECs in the recipient spinal cord .	5352
@NP	Presence	5352
@NP	transgenic pig donor OECs	5364
@NP	the recipient spinal cord	5393
@NP	OECs	5420
@NP	the fluorescent membrane marker , CFDA	5438
@NP	the fluorescent membrane marker	5438
@NP	CFDA	5471
@NP	SE	5477
@NP	the dorsal columns	5496
@NP	3 weeks	5515
@NP	cell transplantation	5529
@NP	The calibration bar	5551
@NP	20 μm	5586
@NP	Figure 5 .	5594
@NP	Figure	5594
@NP	5	5601
@NP	Ultrastructural characteristics	5604
@NP	regenerated axons following transgenic pig OEC and Schwann cells transplantation	5639
@NP	regenerated axons	5639
@NP	transgenic pig OEC and Schwann cells transplantation	5667
@NP	The tissue	5721
@NP	electrophysiological recordings	5757
@NP	Low power electron micrographs	5804
@NP	regenerated myelinated axons	5838
@NP	the fasciculus gracilis	5870
@NP	the dorsal columns	5897
@NP	OEC -LRB- A -RRB- and Schwann cell -LRB- B -RRB- transplantation	5926
@NP	OEC -LRB- A -RRB-	5926
@NP	OEC	5926
@NP	A	5931
@NP	Schwann cell -LRB- B -RRB- transplantation	5938
@NP	Schwann cell	5938
@NP	B	5952
@NP	transplantation	5955
@NP	The micrographs	5972
@NP	the lesion site	6013
@NP	the cell bodies -LRB- dorsal root ganglia -RRB- of the transected	6044
@NP	the cell bodies -LRB- dorsal root ganglia -RRB-	6044
@NP	the cell bodies	6044
@NP	dorsal root ganglia	6061
@NP	the transected	6085
@NP	sensory neurons	6110
@NP	the presence	6132
@NP	small clusters of regenerated axons following OEC transplantation	6148
@NP	small clusters	6148
@NP	regenerated axons following OEC transplantation	6166
@NP	regenerated axons	6166
@NP	OEC transplantation	6194
@NP	individual axons	6219
@NP	Schwann cell transplantation	6255
@NP	Higher power electron micrographs	6285
@NP	formation	6328
@NP	OECs -LRB- C -RRB- and Schwann cells -LRB- D -RRB-	6358
@NP	OECs -LRB- C -RRB-	6358
@NP	OECs	6358
@NP	C	6364
@NP	Schwann cells -LRB- D -RRB-	6371
@NP	Schwann cells	6371
@NP	D	6386
@NP	the presence of a basement	6408
@NP	the presence	6408
@NP	a basement	6424
@NP	D	6483
@NP	Transgenic Expression OECs and Schwann cells	6488
@NP	transgenic pigs expressing the human complement inhibitor , hCD59	6552
@NP	transgenic pigs	6552
@NP	the human complement inhibitor , hCD59	6579
@NP	the human complement inhibitor	6579
@NP	hCD59	6611
@NP	The transgenically derived OECs and Schwann cells	6618
@NP	The transgenically derived OECs	6618
@NP	Schwann cells	6654
@NP	Experimental Protocol	6698
@NP	Cells	6721
@NP	flow cytometry	6744
@NP	transgene expression	6769
@NP	The antibody , PT85A ,	6791
@NP	The antibody	6791
@NP	PT85A	6805
@NP	Swine Leukocyte Antigen -LRB- SLA -RRB- class I	6854
@NP	Swine Leukocyte Antigen -LRB- SLA -RRB-	6854
@NP	Swine Leukocyte Antigen	6854
@NP	SLA	6879
@NP	class I	6884
@NP	a positive control -LRB- Fig. 1 -RRB-	6906
@NP	a positive control	6906
@NP	Fig. 1	6926
@NP	It	6935
@NP	SLA class	6967
@NP	I expression	6977
@NP	the transgenic line	6998
@NP	a murine major histocompatibility class I promoter expression construct	7037
@NP	H2Kb-hCD59 -LRB- ref	7110
@NP	10 -RRB- .	7127
@NP	Indirect immunofluorescence analysis	7132
@NP	the transgene	7185
@NP	the cell surface	7216
@NP	both Schwann cells and OECs	7236
@NP	Schwann cells	7241
@NP	OECs	7259
@NP	the hCD59 transgenic pig -LRB- Fig. 1 -RRB-	7278
@NP	the hCD59 transgenic pig	7278
@NP	Fig. 1	7304
@NP	the concentration of endogenous SLA class I expression	7328
@NP	the concentration	7328
@NP	endogenous SLA class I expression	7349
@NP	both cell types	7400
@NP	the level of transgene expression	7426
@NP	the level	7426
@NP	transgene expression	7439
@NP	an order of magnitude	7464
@NP	an order	7464
@NP	magnitude	7476
@NP	both the OECs and Schwann cells	7494
@NP	the OECs	7499
@NP	Schwann cells	7512
@NP	This	7527
@NP	the result of integration site inactivation effects for these cell types	7541
@NP	the result	7541
@NP	integration site inactivation effects for these cell types	7555
@NP	integration site inactivation effects	7555
@NP	these cell types	7597
@NP	the absence of an enhancer element	7618
@NP	the absence	7618
@NP	an enhancer element	7633
@NP	yet unidentified in the class I gene , specific to ensheathing cells	7657
@NP	yet unidentified	7657
@NP	the class I gene , specific to ensheathing cells	7677
@NP	the class I gene	7677
@NP	specific to ensheathing cells	7695
@NP	Conduction	7726
@NP	regenerated axons	7740
@NP	the transected spinal cord Adult Wistar rats were anesthetized and laminectomies	7765
@NP	the transected spinal cord Adult	7765
@NP	Wistar rats	7798
@NP	anesthetized and laminectomies	7815
@NP	anesthetized	7815
@NP	laminectomies	7832
@NP	the dorsal column lesion	7871
@NP	described previously4	7899
@NP	Lesioned animals	7922
@NP	two cohorts	7966
@NP	a sham transplant group	7979
@NP	vehicle and a cell transplant group	8013
@NP	vehicle	8013
@NP	a cell transplant group	8025
@NP	either transgenic OECs or Schwann cells	8059
@NP	transgenic OECs	8066
@NP	Schwann cells	8085
@NP	The cell transplant group	8100
@NP	injections of about 30,000 cells/μl	8135
@NP	injections	8135
@NP	30,000 cells/μl	8155
@NP	Experimental Protocol	8187
@NP	Four to five weeks	8210
@NP	transection of the dorsal columns	8235
@NP	transection	8235
@NP	the dorsal columns	8250
@NP	the spinal cords	8270
@NP	electrophysiological analysis	8314
@NP	a recording chamber -LRB- see Experimental Protocol -RRB-	8347
@NP	a recording chamber	8347
@NP	Experimental Protocol	8372
@NP	The completeness of the lesion	8396
@NP	The completeness	8396
@NP	the lesion	8416
@NP	anatomical techniques	8459
@NP	only those spinal cords	8486
@NP	histologically complete transections of their dorsal columns	8544
@NP	histologically complete transections	8544
@NP	their dorsal columns	8584
@NP	analysis	8619
@NP	The surface of the dorsal columns	8629
@NP	The surface	8629
@NP	the dorsal columns	8644
@NP	a silver wire electrode caudal	8683
@NP	the transection site	8717
@NP	afferent sensory axons	8760
@NP	dorsal root ganglia	8800
@NP	they	8823
@NP	the fasciculus gracilis of the dorsal columns	8843
@NP	the fasciculus gracilis	8843
@NP	the dorsal columns	8870
@NP	Glass microelectrodes	8890
@NP	field potentials	8932
@NP	the propagating action potentials	8952
@NP	the midline surface of the dorsal columns -LRB- Fig. 2A -RRB-	8991
@NP	the midline surface	8991
@NP	the dorsal columns -LRB- Fig. 2A -RRB-	9014
@NP	the dorsal columns	9014
@NP	Fig. 2A	9034
@NP	Virtually no electrical activity	9044
@NP	the lesion site in histologically complete non-transplanted rats	9102
@NP	the lesion site	9102
@NP	histologically complete non-transplanted rats	9121
@NP	a lack of regeneration	9178
@NP	a lack	9178
@NP	regeneration	9188
@NP	the lesion site -LRB- Fig. 2B ; n = 9 -RRB-	9208
@NP	the lesion site	9208
@NP	Fig. 2B ; n = 9	9225
@NP	Fig. 2B	9225
@NP	n = 9	9234
@NP	n	9234
@NP	9	9238
@NP	Only a stimulus artifact with no electrophysiological response	9242
@NP	Only a stimulus artifact	9242
@NP	no electrophysiological response	9272
@NP	a recording obtained across a lesion site with no cell transplantation	9324
@NP	a recording	9324
@NP	a lesion site	9352
@NP	no cell transplantation	9371
@NP	transgenic pig OECs	9410
@NP	the transection site	9453
@NP	compound action potentials	9475
@NP	the site of transection -LRB- Fig. 2C -RRB-	9530
@NP	the site	9530
@NP	transection -LRB- Fig. 2C -RRB-	9542
@NP	transection	9542
@NP	Fig. 2C	9555
@NP	7 of 10 rats indicating axonal regeneration through the lesion site	9567
@NP	7	9567
@NP	10 rats indicating axonal regeneration through the lesion site	9572
@NP	10 rats	9572
@NP	axonal regeneration	9591
@NP	the lesion site	9619
@NP	5 mm beyond the lesion site compound	9639
@NP	5 mm	9639
@NP	the lesion site compound	9651
@NP	action potentials	9676
@NP	the transplant groups	9724
@NP	amplitude	9770
@NP	non-transected control spinal cords	9797
@NP	non-transected control	9797
@NP	spinal cords	9820
@NP	Conduction	9834
@NP	the transection site	9865
@NP	both transgenic pig OEC and Schwann cells transplantation	9890
@NP	Conduction velocity	9949
@NP	the inverse slope of a plot of latency versus distance for several points	9989
@NP	the inverse slope	9989
@NP	a plot of latency versus distance for several points	10010
@NP	a plot	10010
@NP	latency versus distance for several points	10020
@NP	latency	10020
@NP	distance for several points	10035
@NP	distance	10035
@NP	several points	10048
@NP	the lesion	10070
@NP	Figure 3A	10082
@NP	conduction velocities	10098
@NP	control	10124
@NP	transection alone	10133
@NP	following transplantation of either OECs or Schwann cells	10155
@NP	following transplantation	10155
@NP	either OECs or Schwann cells	10184
@NP	OECs	10191
@NP	Schwann cells	10199
@NP	Virtually no conduction	10214
@NP	transection	10261
@NP	conduction velocity	10295
@NP	the regenerated axons	10331
@NP	OEC -LRB- 20.98 ± 5.38 m/sec ; n = 7 ; P = 0.002 -RRB-	10363
@NP	OEC	10363
@NP	20.98 ± 5.38 m/sec ; n = 7 ; P = 0.002	10368
@NP	20.98 ± 5.38 m/sec	10368
@NP	20.98 ±	10368
@NP	5.38 m/sec	10376
@NP	n = 7	10388
@NP	n	10388
@NP	7	10392
@NP	P = 0.002	10395
@NP	P	10395
@NP	0.002	10399
@NP	Schwann cells -LRB- 19.09 ± 6.2 m/sec ; n = 5 ; P = 0.033 -RRB-	10409
@NP	Schwann cells	10409
@NP	19.09 ± 6.2 m/sec ; n = 5 ; P = 0.033	10424
@NP	19.09 ± 6.2 m/sec	10424
@NP	19.09 ±	10424
@NP	6.2 m/sec	10432
@NP	n = 5	10443
@NP	n	10443
@NP	5	10447
@NP	P = 0.033	10450
@NP	P	10450
@NP	0.033	10454
@NP	transplantation	10461
@NP	control uninjured spinal cords -LRB- 12.93 ± 2.06 m/sec ; n = 11 -RRB-	10494
@NP	control uninjured spinal cords	10494
@NP	control	10494
@NP	12.93 ±	10526
@NP	2.06 m/sec ; n = 11	10534
@NP	2.06 m/sec	10534
@NP	n = 11	10546
@NP	n	10546
@NP	11	10550
@NP	There	10555
@NP	no difference	10565
@NP	conduction velocity between OEC	10582
@NP	conduction velocity	10582
@NP	OEC	10610
@NP	Schwann cells transplanted groups -LRB- P = 0.28 -RRB-	10618
@NP	Schwann cells	10618
@NP	transplanted groups -LRB- P = 0.28 -RRB-	10632
@NP	transplanted groups	10632
@NP	P	10653
@NP	0.28	10657
@NP	The rapid conduction velocities in the transplanted spinal cords	10664
@NP	The rapid conduction velocities	10664
@NP	the transplanted spinal cords	10699
@NP	the axons	10743
@NP	histological analysis	10785
@NP	Recognizable	10808
@NP	compound action potentials	10837
@NP	at least 14 mm -LRB- length of recording chamber -RRB-	10882
@NP	at least 14 mm	10882
@NP	length of recording chamber	10898
@NP	length	10898
@NP	recording chamber	10908
@NP	the transection site in both OEC and Schwann cells	10934
@NP	the transection site	10934
@NP	both OEC and Schwann cells	10958
@NP	OEC	10963
@NP	Schwann cells	10971
@NP	dorsal columns	10998
@NP	Plots	11014
@NP	compound action potentialsamplitude	11023
@NP	a percent of the first wave versus distance beyond the lesion site	11062
@NP	a percent	11062
@NP	the first wave versus distance beyond the lesion site	11075
@NP	the first wave	11075
@NP	distance beyond the lesion site	11097
@NP	distance	11097
@NP	the lesion site	11113
@NP	control , OEC and Schwann cells transplantation in Figure 3B	11143
@NP	control , OEC and Schwann cells transplantation	11143
@NP	Figure 3B	11193
@NP	Control and transplant groups	11204
@NP	attenuation of the responses	11241
@NP	attenuation	11241
@NP	the responses	11256
@NP	increasing conduction distance	11275
@NP	The attenuation	11307
@NP	the result of temporal and spatial dispersion of the axons	11335
@NP	the result	11335
@NP	temporal and spatial dispersion	11349
@NP	the axons	11384
@NP	Both OEC and Schwann cells transplant groups	11395
@NP	Both OEC and Schwann cells	11395
@NP	transplant groups	11422
@NP	less relative attenuation	11450
@NP	distance particularly more	11481
@NP	distance	11481
@NP	the first several millimeters of conduction	11513
@NP	the first several millimeters	11513
@NP	conduction	11546
@NP	controls	11574
@NP	We	11584
@NP	this	11613
@NP	the geometric complexity of lesioned cord at and near the lesion site	11638
@NP	the geometric complexity	11638
@NP	lesioned cord at and near the lesion site	11666
@NP	lesioned cord	11666
@NP	the lesion site	11692
@NP	the axons	11709
@NP	a tortuous trajectory	11728
@NP	this region , which is reflected as greater stability of the response amplitude	11753
@NP	this region	11753
@NP	greater stability of the response amplitude	11788
@NP	greater stability	11788
@NP	the response amplitude	11809
@NP	These results	11833
@NP	axonal regeneration as assayed electrophysiologically	11861
@NP	axonal regeneration as	11861
@NP	a significant longitudinal distance	11928
@NP	the spinal cord	11971
@NP	Axonal signaling	11988
@NP	the discharge of several action potentials	12030
@NP	the discharge	12030
@NP	several action potentials	12047
@NP	the regenerated axons	12090
@NP	high frequency discharge	12126
@NP	we	12151
@NP	their frequency-response properties	12163
@NP	Figure 3C	12200
@NP	the attenuation	12216
@NP	the compound action potential	12235
@NP	increasing stimulus frequency for control , OEC and Schwann cells	12270
@NP	increasing stimulus frequency	12270
@NP	control , OEC and Schwann cells	12304
@NP	transplant groups	12335
@NP	5 mm	12362
@NP	the lesion site	12374
@NP	frequencies up to 400 Hz	12394
@NP	frequencies	12394
@NP	400 Hz	12412
@NP	there	12419
@NP	no difference	12429
@NP	the intact control	12451
@NP	transplant groups	12474
@NP	the regenerated axons	12508
@NP	stable high frequency discharge properties	12539
@NP	normal axons	12593
@NP	paired pulse experiments	12617
@NP	the refractory properties of the axons	12657
@NP	the refractory properties	12657
@NP	the axons	12686
@NP	all groups -LRB- Fig. 3D -RRB-	12713
@NP	all groups	12713
@NP	Fig. 3D	12725
@NP	Localization	12735
@NP	donor cells and morphology of regenerated axons	12759
@NP	donor cells and morphology	12759
@NP	regenerated axons	12789
@NP	A limited number of spinal cords	12807
@NP	A limited number	12807
@NP	spinal cords	12827
@NP	transplants	12849
@NP	fluorescently labeled donor cells	12864
@NP	Experimental Protocol	12903
@NP	their survival and presence	12941
@NP	the host	12972
@NP	Confocal imaging of 5 - -LRB- and -6 -RRB-	12982
@NP	Confocal imaging	12982
@NP	5	13002
@NP	and -6	13005
@NP	carboxyfluoresceine diacetate	13013
@NP	succinimidyl ester	13044
@NP	CFDA	13064
@NP	SE	13070
@NP	loaded transplanted OECs -LRB- Fig. 4 -RRB-	13074
@NP	loaded transplanted OECs	13074
@NP	Fig. 4	13100
@NP	Schwann cells -LRB- not shown -RRB-	13112
@NP	Schwann cells	13112
@NP	transplanted myelin-forming cells	13156
@NP	the dorsal column region for at least 4 weeks	13206
@NP	the dorsal column region	13206
@NP	at least 4 weeks	13235
@NP	transplantation	13258
@NP	several millimeters	13287
@NP	the rostral-caudal axis of the spinal cord	13313
@NP	the rostral-caudal axis	13313
@NP	the spinal cord	13340
@NP	It	13357
@NP	we	13386
@NP	the donor cells	13398
@NP	the margins of the transected cord both rostrally	13419
@NP	the margins	13419
@NP	the transected cord both rostrally	13434
@NP	the	13434
@NP	cord	13449
@NP	the gap of the lesion	13496
@NP	the gap	13496
@NP	the lesion	13507
@NP	The demonstration	13519
@NP	viable transplanted cells	13542
@NP	the spinal cord spanning the lesion gap	13584
@NP	the spinal cord	13584
@NP	the lesion gap	13609
@NP	a ` bridge ' of donor cells	13639
@NP	a ` bridge '	13639
@NP	donor cells	13653
@NP	the in vitro electrophysiological studies the spinal cords	13700
@NP	the in vitro electrophysiological studies	13700
@NP	electrophysiological studies	13713
@NP	the spinal cords	13742
@NP	histological analysis	13788
@NP	standard plastic embedding protocols	13816
@NP	Experimental Protocol	13858
@NP	Histological examination of semi-thin sections	13882
@NP	Histological examination	13882
@NP	semi-thin sections	13910
@NP	the surgical protocol	13944
@NP	a complete transection of the dorsal columns	13988
@NP	a complete transection	13988
@NP	the dorsal columns	14014
@NP	minimal damage	14038
@NP	the ventral horns	14056
@NP	The dorsal columns in all lesioned animals used in this study	14075
@NP	The dorsal columns	14075
@NP	all lesioned animals used in this study	14097
@NP	all lesioned animals	14097
@NP	this study	14126
@NP	Histological examination	14165
@NP	transected dorsal columns with transplanted transgenic pig OECs or Schwann cells	14193
@NP	transected dorsal columns	14193
@NP	transplanted transgenic pig OECs or Schwann cells	14224
@NP	transplanted transgenic pig OECs	14224
@NP	Schwann cells	14260
@NP	dispersed axons	14283
@NP	Schwann cell-like patterns	14310
@NP	myelination	14340
@NP	large cytoplasmic and nuclear regions and the presence of a basement membrane	14353
@NP	large cytoplasmic and nuclear regions and the presence	14353
@NP	large cytoplasmic and nuclear regions	14353
@NP	the presence	14395
@NP	a basement membrane	14411
@NP	within and rostral	14437
@NP	within	14437
@NP	rostral	14448
@NP	the transection sites	14459
@NP	The electron micrographs in Figure 5	14482
@NP	The electron micrographs	14482
@NP	Figure 5	14510
@NP	the presence	14531
@NP	a peripheral pattern	14547
@NP	myelination for both transgenic pig OEC and Schwann cell transplantation	14571
@NP	myelination	14571
@NP	both transgenic pig OEC and Schwann cell transplantation	14587
@NP	The patterns of axonal distribution	14645
@NP	The patterns	14645
@NP	axonal distribution	14661
@NP	slightly different between OEC and Schwann cell transplantation	14686
@NP	OEC and Schwann	14713
@NP	axons in OEC transplanted lesions	14762
@NP	axons	14762
@NP	OEC transplanted lesions	14771
@NP	small bundles of 3	14824
@NP	small bundles	14824
@NP	3	14841
@NP	8 axons with a large surrounding extracellular space -LRB- Fig. 5A -RRB-	14843
@NP	8 axons	14843
@NP	a large surrounding extracellular space -LRB- Fig. 5A -RRB-	14856
@NP	a large surrounding extracellular space	14856
@NP	Fig. 5A	14897
@NP	myelinated axonal profiles in Schwann	14915
@NP	myelinated axonal profiles	14915
@NP	Schwann	14945
@NP	cell transplanted lesions seemed to be more random	14953
@NP	cell	14953
@NP	transplanted lesions	14958
@NP	Fig. 5B	15005
@NP	Electron microscopic analysis of the spinal cords	15015
@NP	Electron microscopic analysis	15015
@NP	the spinal cords	15048
@NP	both OEC and SC	15080
@NP	OEC	15085
@NP	SC	15093
@NP	transplanted spinal cords	15096
@NP	relatively thick myelin surrounded by a basement membrane	15134
@NP	relatively thick myelin	15134
@NP	a basement membrane	15172
@NP	Fig. 5C -- D	15193
@NP	Fig. 5C	15193
@NP	D	15201
@NP	Consistent	15205
@NP	the electrophysiological evidence	15221
@NP	myelinated axons	15258
@NP	dorsal column lesions	15303
@NP	semi-thin plastic-embedded sections of lesioned dorsal columns	15326
@NP	semi-thin plastic-embedded sections	15326
@NP	lesioned dorsal columns	15365
@NP	Experimental Protocol	15394
@NP	the presence	15426
@NP	many axons	15442
@NP	the characteristic appearance of peripherally myelinated axons within	15461
@NP	the characteristic appearance	15461
@NP	axons	15518
@NP	adjacent to OEC or Schwann cell transplanted lesions	15535
@NP	OEC or Schwann cell	15547
@NP	Counts of myelinated axons	15589
@NP	Counts	15589
@NP	myelinated axons	15599
@NP	the lesion	15639
@NP	an increase	15659
@NP	the numbers of myelinated axons	15674
@NP	the numbers	15674
@NP	myelinated axons	15689
@NP	the transection site	15723
@NP	animals receiving transplants of transgenic pig OECs or Schwann cells	15747
@NP	animals	15747
@NP	transplants of transgenic pig OECs or Schwann cells	15765
@NP	transplants	15765
@NP	transgenic pig OECs or Schwann cells	15780
@NP	Lesions transplanted with pig OECs or Schwann cells	15818
@NP	Lesions	15818
@NP	pig OECs or Schwann cells	15844
@NP	an average of 304 ± 56 -LRB- n = 10 -RRB- and 268 ± 61 -LRB- n = 4 -RRB-	15880
@NP	an average of 304 ± 56 -LRB- n = 10 -RRB- and 268 ± 61	15880
@NP	an average of 304 ± 56 -LRB- n = 10 -RRB-	15880
@NP	an average	15880
@NP	304 ± 56 -LRB- n = 10 -RRB-	15894
@NP	304 ± 56	15894
@NP	n	15904
@NP	10	15908
@NP	268 ± 61	15916
@NP	268 ±	15916
@NP	61	15922
@NP	n	15926
@NP	4	15930
@NP	peripheral-like myelinated axons	15948
@NP	the lesion	15990
@NP	only 112 ± 22 -LRB- n = 9 -RRB- axons in control lesions	16015
@NP	only 112 ± 22 -LRB- n = 9 -RRB- axons	16015
@NP	n = 9	16030
@NP	n	16030
@NP	= 9	16032
@NP	control lesions	16046
@NP	Numbers	16063
@NP	myelinated axons	16074
@NP	the lesion in OEC and Schwann cell transplanted lesions combined	16108
@NP	the lesion in OEC	16108
@NP	the lesion	16108
@NP	OEC	16122
@NP	Schwann cell transplanted lesions combined	16130
@NP	Schwann cell transplanted lesions	16130
@NP	control lesions at P	16201
@NP	control lesions	16201
@NP	P	16220
@NP	0.003 , respectively -LRB- unpaired two tailed Student 's t test -RRB-	16224
@NP	0.003 , respectively	16224
@NP	0.003	16224
@NP	unpaired two tailed Student 's t test	16245
@NP	unpaired two	16245
@NP	Student 's t test	16265
@NP	Student 's	16265
@NP	Discussion Transplantation of allogeneic OECs	16285
@NP	Discussion Transplantation	16285
@NP	allogeneic OECs	16315
@NP	refs	16332
@NP	9 and 11 -RRB- or Schwann cells	16338
@NP	9 and 11 -RRB-	16338
@NP	9	16338
@NP	11	16344
@NP	Schwann cells	16351
@NP	refs	16366
@NP	8 and 12 -RRB-	16372
@NP	8	16372
@NP	12	16378
@NP	demyelinated axons	16413
@NP	axonal regeneration of transected axons	16454
@NP	axonal regeneration	16454
@NP	transected axons	16477
@NP	the rat spinal cord3	16497
@NP	,5,13,14	16517
@NP	A recent study	16527
@NP	transplantation or human OECs	16557
@NP	transplantation	16557
@NP	human OECs	16576
@NP	the immunosuppressed rat spinal cord15	16603
@NP	the feasibility of xenotransplantation	16658
@NP	the feasibility	16658
@NP	xenotransplantation	16677
@NP	axons	16707
@NP	Electrophysiological and histological examination	16714
@NP	transected dorsal columns in this study	16767
@NP	transected dorsal columns	16767
@NP	this study	16796
@NP	the conclusion	16815
@NP	transplantation of either transgenic pig OECs or Schwann cells	16835
@NP	transplantation	16835
@NP	either transgenic pig OECs or Schwann cells	16854
@NP	transgenic pig OECs	16861
@NP	Schwann cells	16884
@NP	long distance regeneration of functionally remyelinated axons	16909
@NP	long distance regeneration	16909
@NP	functionally remyelinated axons	16939
@NP	the spinal cord	16978
@NP	Compound action potentials	16995
@NP	14 mm -LRB- recording chamber length -RRB- rostral	17046
@NP	14 mm -LRB- recording chamber length -RRB-	17046
@NP	14 mm	17046
@NP	recording chamber length	17053
@NP	histologically complete dorsal column transections	17090
@NP	cell transplants	17159
@NP	The conduction velocity	17177
@NP	frequency-response characteristics of the regenerated axons crossing the lesion	17205
@NP	frequency-response characteristics	17205
@NP	the regenerated axons crossing the lesion	17243
@NP	the regenerated axons	17243
@NP	the lesion	17274
@NP	myelinated axons	17304
@NP	histological sections	17326
@NP	numerous Schwann	17357
@NP	peripheral pattern	17385
@NP	the dorsal column area rostral	17437
@NP	the lesion of the rostrally projecting sensory axons	17471
@NP	the lesion	17471
@NP	the rostrally projecting sensory axons	17485
@NP	lesioned controls -LRB- no transplant -RRB-	17528
@NP	lesioned controls	17528
@NP	no transplant	17547
@NP	virtually no conduction	17562
@NP	the transection site	17606
@NP	The conduction	17628
@NP	the lesion site	17650
@NP	transplanted recipients	17669
@NP	the absence of conduction in non-transplanted animals	17697
@NP	the absence	17697
@NP	conduction in non-transplanted animals	17712
@NP	conduction	17712
@NP	non-transplanted animals	17726
@NP	experiments using rat donor cells4	17766
@NP	experiments	17766
@NP	rat donor cells4	17784
@NP	This	17802
@NP	cross-species transplantation of genetically altered cells	17822
@NP	cross-species transplantation	17822
@NP	genetically altered cells	17855
@NP	the repair potential of the cells in immunosuppressed rats	17897
@NP	the repair potential	17897
@NP	the cells in immunosuppressed rats	17921
@NP	the cells	17921
@NP	immunosuppressed rats	17934
@NP	the electrophysiological data	17966
@NP	functionally remyelinated axons	18017
@NP	it	18050
@NP	the CAPs of both OEC and Schwann cell-induced regenerated axons	18072
@NP	the CAPs	18072
@NP	both OEC and Schwann cell-induced regenerated axons	18084
@NP	both OEC and Schwann	18084
@NP	cell-induced regenerated axons	18105
@NP	conduction velocities greater	18140
@NP	conduction velocities	18140
@NP	control	18175
@NP	axons	18203
@NP	regenerated axons	18210
@NP	repetitive stimuli	18253
@NP	frequencies up to 200 Hz	18275
@NP	frequencies	18275
@NP	200 Hz	18293
@NP	these results	18316
@NP	a rapid and secure conduction pathway	18344
@NP	transplantation of either transgenic pig OECs or Schwann cells	18402
@NP	transplantation	18402
@NP	either transgenic pig OECs or Schwann cells	18421
@NP	transgenic pig OECs	18428
@NP	Schwann cells	18451
@NP	the transected dorsal column lesion	18470
@NP	the	18470
@NP	dorsal column lesion	18485
@NP	Electron microscopic analysis	18507
@NP	both OECs and Schwann cells	18552
@NP	OECs	18557
@NP	Schwann cells	18566
@NP	a peripheral-type of myelination pattern	18590
@NP	a peripheral-type	18590
@NP	myelination pattern	18611
@NP	large cytoplasmic and nuclear components surrounding the myelin	18636
@NP	large cytoplasmic and nuclear components	18636
@NP	the myelin	18689
@NP	the presence of a basal lamina , which are characteristic of peripheral myelin16	18705
@NP	the presence	18705
@NP	a basal lamina , which are characteristic	18721
@NP	a basal lamina	18721
@NP	peripheral myelin16	18765
@NP	extracellular collagen deposition	18796
@NP	peripheral myelin	18858
@NP	cells	18884
@NP	the spinal cord	18907
@NP	The myelinated axons following OEC transplantation	18924
@NP	The myelinated axons	18924
@NP	OEC transplantation	18955
@NP	bundles	18996
@NP	myelinated axons	19013
@NP	Schwann cell transplantation	19060
@NP	Li et al. 3	19090
@NP	Li	19090
@NP	et al. 3	19093
@NP	et al.	19093
@NP	3	19099
@NP	a similar bundling	19108
@NP	myelinated axons	19130
@NP	transplantation of OECs in a electrolytic corticospinal lesion site	19157
@NP	transplantation	19157
@NP	OECs in a electrolytic corticospinal lesion site	19176
@NP	OECs	19176
@NP	a electrolytic corticospinal lesion site	19184
@NP	The bundling	19226
@NP	regenerated myelinated axons that was typical in the OEC transplants	19242
@NP	regenerated myelinated axons	19242
@NP	the OEC transplants	19291
@NP	there	19325
@NP	some differences	19338
@NP	the pattern	19358
@NP	axonal regeneration following transplantation of OECs versus Schwann cells	19373
@NP	axonal regeneration	19373
@NP	transplantation of OECs versus Schwann cells	19403
@NP	transplantation	19403
@NP	OECs versus Schwann cells	19422
@NP	OECs	19422
@NP	Schwann cells	19434
@NP	spite of these anatomical differences	19452
@NP	spite	19452
@NP	these anatomical differences	19461
@NP	we	19491
@NP	no difference	19500
@NP	the electrophysiological properties	19517
@NP	transgenic pig OEC or Schwann cell transplantation	19563
@NP	transgenic pig OEC	19563
@NP	Schwann cell transplantation	19585
@NP	Histological examination of the spinal cords 4 -- 5 weeks after injection	19615
@NP	Histological examination	19615
@NP	the spinal cords 4 -- 5 weeks after injection	19643
@NP	the spinal cords 4	19643
@NP	the spinal cords	19643
@NP	4	19660
@NP	5 weeks after injection	19662
@NP	5 weeks	19662
@NP	injection	19676
@NP	the spinal cord	19701
@NP	axons and transplanted cells	19754
@NP	axons	19754
@NP	transplanted cells	19764
@NP	the transition zone	19799
@NP	The injury site	19831
@NP	normal oligodendrocytemyelinated axons	19866
@NP	regenerated axons that exhibited a peripheral pattern of myelination	19929
@NP	regenerated axons	19929
@NP	a peripheral pattern of myelination	19962
@NP	a peripheral pattern	19962
@NP	myelination	19986
@NP	The dorsal columns	19999
@NP	several cuts	20048
@NP	sparing of residual intact axons within the lesion zone	20065
@NP	sparing	20065
@NP	residual intact axons within the lesion zone	20076
@NP	residual intact axons	20076
@NP	the lesion zone	20105
@NP	One proposal	20152
@NP	the fusion of the cut spinal cord	20176
@NP	the fusion	20176
@NP	the cut spinal cord	20190
@NP	the severe injury	20216
@NP	the OECs and Schwann cells	20242
@NP	the lesion zone	20292
@NP	guide cells for the axons	20322
@NP	guide cells	20322
@NP	the axons	20338
@NP	extent	20351
@NP	the lesion	20365
@NP	a hospitable regenerative environment	20389
@NP	These cells	20428
@NP	inhibitory proteins that induce growth cone collapse as do oligodendrocytes	20455
@NP	inhibitory proteins	20455
@NP	growth cone collapse as do oligodendrocytes	20487
@NP	growth cone collapse	20487
@NP	oligodendrocytes	20514
@NP	CNS axons	20532
@NP	peripheral nerve grafts17	20565
@NP	an environment	20598
@NP	glial inhibitory proteins	20619
@NP	antibodies18	20670
@NP	The transplanted OECs and Schwann cells	20684
@NP	The transplanted OECs	20684
@NP	Schwann cells	20710
@NP	trophic support	20743
@NP	axonal regeneration	20772
@NP	both OECs -LRB- ref .19 -RRB- and Schwann cells -LRB- ref	20793
@NP	OECs -LRB- ref .19 -RRB-	20798
@NP	OECs	20798
@NP	ref .19	20804
@NP	Schwann cells -LRB- ref	20816
@NP	Schwann cells	20816
@NP	ref	20831
@NP	20 -RRB- can express NGF P75 receptors and Schwann cells	20836
@NP	20 -RRB-	20836
@NP	NGF P75 receptors and Schwann cells	20852
@NP	NGF -LRB- ref	20909
@NP	NGF	20909
@NP	ref	20914
@NP	21	20919
@NP	axotomy	20929
@NP	It	20938
@NP	NGF and NGF receptor interactions or other neurotrophins	20973
@NP	NGF and NGF receptor interactions	20973
@NP	other neurotrophins	21010
@NP	the enhanced regenerative capacity	21044
@NP	CNS axons after OEC and Schwann cell transplantation	21082
@NP	CNS axons	21082
@NP	OEC and Schwann cell transplantation	21098
@NP	The demonstration	21136
@NP	OECs and SCs derived from hCD59 transgenic pigs	21159
@NP	OECs and SCs	21159
@NP	hCD59 transgenic pigs	21185
@NP	axonal regeneration of functionally intact axons	21218
@NP	axonal regeneration	21218
@NP	functionally intact axons	21241
@NP	the potential	21278
@NP	cell therapy approaches	21295
@NP	engineered xenogeneic cells	21325
@NP	damaged CNS axonal tracts	21363
@NP	Contusive spinal cord injury	21390
@NP	transection of axons	21439
@NP	transection	21439
@NP	axons	21454
@NP	demyelination of long tracts	21484
@NP	demyelination	21484
@NP	long tracts	21501
@NP	addition to demyelination	21527
@NP	addition	21527
@NP	demyelination	21539
@NP	axonal transection	21554
@NP	early several sclerosis lesions 22	21592
@NP	early several sclerosis lesions	21592
@NP	22	21624
@NP	Engineered pig OECs and Schwann cells	21628
@NP	the hCD59 gene	21690
@NP	at least some degree of axonal regeneration and form	21719
@NP	at least some degree	21719
@NP	axonal regeneration and form	21743
@NP	These cells	21780
@NP	large numbers	21822
@NP	a donor cell for cell therapy	21858
@NP	a donor cell	21858
@NP	cell therapy	21875
@NP	the demyelinated or injured spinal cord	21909
@NP	the	21909
@NP	spinal cord	21937
@NP	there	21961
@NP	several clinical applications for the use of porcine tissues	21971
@NP	several clinical applications	21971
@NP	the use of porcine tissues	22005
@NP	the use	22005
@NP	porcine tissues	22016
@NP	example	22037
@NP	the treatment	22046
@NP	Parkinson 's disease patients	22063
@NP	Parkinson 's	22063
@NP	fetal porcine neural cells1 ,23	22097
@NP	fetal porcine neural cells1	22097
@NP	,23	22124
@NP	the use	22131
@NP	porcine hepatocytes for liver support systems in cases of acute liver failure1	22142
@NP	porcine hepatocytes	22142
@NP	liver support systems in cases of acute liver failure1	22166
@NP	liver support systems	22166
@NP	cases of acute liver failure1	22191
@NP	cases	22191
@NP	acute liver failure1	22200
@NP	,24	22220
@NP	the success of these applications	22234
@NP	the success	22234
@NP	these applications	22249
@NP	the poor understanding	22288
@NP	the mechanisms	22314
@NP	many cases	22342
@NP	loss of function and rejection of the transplanted tissue	22356
@NP	loss	22356
@NP	function and rejection	22364
@NP	the transplanted tissue	22390
@NP	Many porcine cell types	22415
@NP	Many porcine	22415
@NP	cell types	22428
@NP	transplantation	22450
@NP	cardiomyocytes25 or OECs -LRB- refs	22475
@NP	cardiomyocytes25	22475
@NP	OECs -LRB- refs	22495
@NP	9 and 11 -RRB- and Schwann cells	22507
@NP	9 and 11 -RRB-	22507
@NP	9	22507
@NP	11	22513
@NP	Schwann cells	22521
@NP	ref	22536
@NP	spinal cord repair	22548
@NP	a humoral and cellular immune response2	22597
@NP	the demonstration	22648
@NP	genetically modified OECs and Schwann cells	22671
@NP	genetically modified OECs	22671
@NP	Schwann cells	22701
@NP	allotransplants4	22737
@NP	these engineered cells	22763
@NP	humoral immunity	22815
@NP	the use of transgenic porcine tissues for human therapy	22842
@NP	the use	22842
@NP	transgenic porcine tissues for human therapy	22853
@NP	transgenic porcine tissues	22853
@NP	human therapy	22884
@NP	transgenic porcine cells	22908
@NP	several advantages	22938
@NP	human fetal tissue	22962
@NP	availability	22990
@NP	quality control	23004
@NP	the tissues obtained and timing of cell collection and reproducibility	23023
@NP	the tissues obtained	23023
@NP	the tissues	23023
@NP	timing of cell collection and reproducibility	23048
@NP	timing	23048
@NP	cell collection and reproducibility	23058
@NP	Experimental protocol Cell preparation and culture	23096
@NP	The anterior tips of the olfactory bulbs	23147
@NP	The anterior tips	23147
@NP	the olfactory bulbs	23168
@NP	the sciatic nerves of transgenic pigs	23192
@NP	the sciatic nerves	23192
@NP	transgenic pigs	23214
@NP	1-mm pieces	23256
@NP	Sciatic nerve pieces	23269
@NP	90 min -LRB- 30 -- 40 min for OEC collections -RRB- at 37 °C in DMEM	23314
@NP	90 min -LRB- 30 -- 40 min for OEC collections -RRB-	23314
@NP	30	23322
@NP	40 min for OEC collections	23325
@NP	40 min	23325
@NP	OEC collections	23336
@NP	37 °C in DMEM	23356
@NP	37 °C	23356
@NP	DMEM	23364
@NP	1 mg/ml each of collagenase A and D ; Boheringer Mannheim -RRB-	23374
@NP	1 mg/ml	23374
@NP	each	23382
@NP	collagenase A and D ; Boheringer Mannheim	23390
@NP	collagenase A and D	23390
@NP	Boheringer Mannheim	23411
@NP	continuous agitation	23437
@NP	The resulting mixture	23459
@NP	cells	23506
@NP	2.5 mg/ml trypsin -LRB- Boehringer Manheim , Germany -RRB-	23535
@NP	2.5 mg/ml trypsin	23535
@NP	Boehringer Manheim	23554
@NP	Germany	23574
@NP	0.5 mg/ml DNAse for 15 -- 30 min -LRB- 10 min	23587
@NP	0.5 mg/ml DNAse for 15	23587
@NP	0.5 mg/ml DNAse	23587
@NP	15	23606
@NP	30 min -LRB- 10 min	23609
@NP	30 min	23609
@NP	10 min	23617
@NP	10	23617
@NP	min	23620
@NP	OEC collections	23629
@NP	OEC	23629
@NP	collections	23633
@NP	Cell suspensions	23647
@NP	Dulbecco 's modified Eagle 's medium -LRB- DMEM -RRB- with 10 % fetal calf	23705
@NP	Dulbecco 's	23705
@NP	Eagle 's medium -LRB- DMEM -RRB-	23725
@NP	Eagle 's medium	23725
@NP	Eagle 's	23725
@NP	DMEM	23741
@NP	10 %	23752
@NP	serum	23767
@NP	a flame polished siliconized pipette	23796
@NP	a flame polished	23796
@NP	pipette	23825
@NP	Any large undissociated pieces of tissue	23834
@NP	Any large undissociated pieces	23834
@NP	tissue	23868
@NP	cells	23908
@NP	DMEM and resuspending	23925
@NP	a concentration of 30,000 cells/μl in DMEM for transplantation	23950
@NP	a concentration	23950
@NP	30,000 cells/μl in DMEM for transplantation	23969
@NP	30,000 cells/μl	23969
@NP	DMEM for transplantation	23988
@NP	DMEM	23988
@NP	transplantation	23997
@NP	Enzymatic activity	24014
@NP	10 % fetal calf serum	24050
@NP	medium	24082
@NP	the cells	24093
@NP	DMEM	24124
@NP	them	24149
@NP	30,000 cells/μl in DMEM	24157
@NP	30,000 cells/μl	24157
@NP	DMEM	24176
@NP	Transgenic expression analysis Schwann cell	24182
@NP	OECs isolated from hCD59 transgenic animals	24230
@NP	OECs	24230
@NP	hCD59 transgenic animals	24249
@NP	expression	24291
@NP	the transgene	24305
@NP	indirect immunofluorescence	24322
@NP	the anti-hCD59 mouse monoclonal antibody	24356
@NP	mAb	24398
@NP	MEM-43 -LRB- Biodesign International , Kennebunkport , ME -RRB-	24404
@NP	MEM-43	24404
@NP	Biodesign International	24412
@NP	Kennebunkport	24437
@NP	ME	24452
@NP	a polyclonal anti-hCD59 antibody , ALP-3	24461
@NP	a polyclonal anti-hCD59 antibody	24461
@NP	ALP-3	24495
@NP	26 -RRB- .	24507
@NP	Endogenous expression of SLA class	24512
@NP	Endogenous expression	24512
@NP	SLA class	24537
@NP	I	24547
@NP	the anti-SLA Class I mAb , PT85A -LRB- VARD , Inc. , Pullman , WA -RRB-	24566
@NP	the anti-SLA Class I mAb	24566
@NP	the anti-SLA Class	24566
@NP	I mAb	24585
@NP	PT85A -LRB- VARD , Inc. , Pullman , WA -RRB-	24592
@NP	PT85A	24592
@NP	VARD	24599
@NP	Inc.	24605
@NP	Pullman , WA	24611
@NP	a positive control antibody	24638
@NP	Indirect immunofluorescence	24667
@NP	1 ×	24722
@NP	104 to 1	24726
@NP	× 105 cells	24735
@NP	20 μg/ml of the polyclonal	24752
@NP	20 μg/ml	24752
@NP	the polyclonal	24764
@NP	10 μg/ml of MEM 43 in 1 ×	24787
@NP	10 μg/ml	24787
@NP	MEM 43 in 1 ×	24799
@NP	MEM 43	24799
@NP	1 ×	24809
@NP	PBS	24812
@NP	2 % fetal bovine serum	24821
@NP	Goat anti-rabbit IgG	24844
@NP	polyclonal sera , Zymed , South San Francisco , CA	24866
@NP	polyclonal sera	24866
@NP	Zymed	24883
@NP	South San Francisco	24890
@NP	CA	24911
@NP	goat anti-mouse IgG	24918
@NP	monoclonal sera	24939
@NP	Zymed	24956
@NP	fluorescein isothiocyanate	24963
@NP	FITC	24991
@NP	antisera	25009
@NP	specific antibody binding	25038
@NP	the cell surface	25067
@NP	Cell surface expression	25085
@NP	flow cytometry on a Becton-Dickinson FACSort	25130
@NP	flow cytometry	25130
@NP	a Becton-Dickinson FACSort	25148
@NP	Surgical procedures Adult Wistar rats	25176
@NP	Surgical procedures	25176
@NP	Adult Wistar rats	25196
@NP	ketamine/xylazine -LRB- 75 mg/kg ; 10 mg/kg , i.p. -RRB-	25244
@NP	ketamine/xylazine	25244
@NP	75 mg/kg ; 10 mg/kg , i.p.	25263
@NP	75 mg/kg	25263
@NP	10 mg/kg , i.p.	25273
@NP	10 mg/kg	25273
@NP	a standard lumbar spinal cord dorsal column transection at vertebral level T11	25306
@NP	a standard lumbar spinal cord dorsal column transection	25306
@NP	vertebral level T11	25365
@NP	A sterile laminectomy	25386
@NP	T11 and dorsal column	25425
@NP	several transverse cuts	25465
@NP	a pair	25494
@NP	8.5 cm Vannas-Tubbinegin spring scissors	25504
@NP	Fine Science Tools , Forest City California	25546
@NP	Fine Science Tools	25546
@NP	Forest City California	25566
@NP	the top of the spinal cord	25596
@NP	the top	25596
@NP	the spinal cord	25607
@NP	the central vein	25636
@NP	This surgery	25654
@NP	paraparesis of the hind limbs	25679
@NP	paraparesis	25679
@NP	the hind limbs	25694
@NP	all animal subjected to the procedure	25712
@NP	all animal	25712
@NP	the procedure	25736
@NP	locomotion	25771
@NP	eating , drinking or elimination	25792
@NP	spinal cord transection , 1.0 ml of freshly isolated transgenic pig OECs	25843
@NP	spinal cord transection	25843
@NP	1.0 ml of freshly isolated transgenic pig OECs	25868
@NP	1.0 ml	25868
@NP	freshly isolated transgenic pig OECs	25878
@NP	Schwann cells or control DMEM -LRB- Gibco BRG -RRB-	25916
@NP	Schwann cells	25916
@NP	control DMEM -LRB- Gibco BRG -RRB-	25933
@NP	control DMEM	25933
@NP	Gibco BRG	25947
@NP	the dorsal column	25977
@NP	a drawn glass micropipette	25999
@NP	depths of 0.5	26029
@NP	depths	26029
@NP	0.5	26039
@NP	0.7 mm at two injection sites 0.5 mm rostral and caudal to the lesion	26047
@NP	0.7 mm	26047
@NP	two injection sites 0.5 mm rostral and caudal to the lesion	26057
@NP	two injection sites 0.5 mm rostral	26057
@NP	two injection sites	26057
@NP	0.5 mm rostral	26077
@NP	caudal to the lesion	26096
@NP	caudal	26096
@NP	the lesion	26106
@NP	OECs and Schwann cells	26118
@NP	a concentration	26158
@NP	30,000 cells/μl for a total of 60,000 cells transplanted into each animal	26177
@NP	30,000 cells/μl	26177
@NP	a total of 60,000 cells transplanted into each animal	26197
@NP	a total	26197
@NP	60,000 cells transplanted into each animal	26208
@NP	60,000 cells	26208
@NP	each animal	26239
@NP	Electrophysiological analysis of axonal conduction	26252
@NP	Electrophysiological analysis	26252
@NP	axonal conduction	26285
@NP	Four to five weeks	26303
@NP	spinal cord transection and cell transplantation	26328
@NP	rats	26378
@NP	sodium pentobarbital anesthesia	26401
@NP	75 mg/kg	26434
@NP	The vertebral column from each animal between T5 and L2	26450
@NP	The vertebral column	26450
@NP	each animal between T5 and L2	26476
@NP	each animal	26476
@NP	T5 and L2	26496
@NP	cold dissecting solution	26553
@NP	135 mM choline chloride	26579
@NP	20 mM choline bicarbonate/1 .0 mM KCl ; 1.2 mM KH2PO4 ; 90 mM dextrose	26604
@NP	20 mM choline bicarbonate/1 .0 mM KCl	26604
@NP	20 mM choline	26604
@NP	bicarbonate/1 .0 mM KCl	26618
@NP	1.2 mM KH2PO4	26642
@NP	1.2 mM	26642
@NP	KH2PO4	26649
@NP	90 mM dextrose	26657
@NP	90 mM	26657
@NP	dextrose	26663
@NP	The spinal cord region between T6 and L1	26674
@NP	The spinal cord region	26674
@NP	T6 and L1	26705
@NP	a recording chamber	26741
@NP	zero calcium	26788
@NP	Krebs ' solution	26810
@NP	Krebs '	26810
@NP	124 mM NaCl	26827
@NP	3mM KCl	26840
@NP	2.0 mM MgCl2	26849
@NP	26 mM NaHCO3	26863
@NP	1.3 NaHPO4	26877
@NP	10 mM dextrose	26889
@NP	95 % O2/5 % CO2	26920
@NP	95 %	26920
@NP	O2/5 %	26924
@NP	a drip rate of 4.0	26936
@NP	a drip rate	26936
@NP	4.0	26951
@NP	5.5 ml/min at room temperature for 30 min	26955
@NP	5.5 ml/min	26955
@NP	room temperature for 30 min	26969
@NP	room temperature	26969
@NP	30 min	26990
@NP	CaCl2 -LRB- 2.0 mM -RRB-	26998
@NP	CaCl2	26998
@NP	2.0 mM	27005
@NP	the solution	27031
@NP	electrophysiological recordings	27045
@NP	2 h	27091
@NP	36 °C	27104
@NP	The site of the spinal cord transection	27110
@NP	The site	27110
@NP	the spinal cord transection	27122
@NP	the presence	27168
@NP	a pale yellow scar	27184
@NP	the dorsal surface of the spinal cord	27231
@NP	the dorsal surface	27231
@NP	the spinal cord	27253
@NP	A bipolar silver stimulating electrode	27270
@NP	A bipolar silver	27270
@NP	electrode	27299
@NP	the dorsal column 1 mm caudal to the transection site	27327
@NP	the dorsal column 1 mm caudal	27327
@NP	the transection site	27360
@NP	Electrical responses	27382
@NP	glass micro-electrodes	27422
@NP	2M NaC1 -LRB- 3 -- 10 MΩ resistance -RRB-	27457
@NP	2M NaC1	27457
@NP	3 -- 10 MΩ resistance	27466
@NP	3	27466
@NP	10 MΩ resistance	27469
@NP	the surface of the dorsal column at successive points	27492
@NP	the surface	27492
@NP	the dorsal column at successive points	27507
@NP	the dorsal column	27507
@NP	successive points	27528
@NP	1 to 15 mm rostral to the lesion site	27551
@NP	1 to 15 mm rostral	27551
@NP	the lesion site	27573
@NP	Stimulus intensity	27590
@NP	25 %	27620
@NP	the strength necessary to elicit maximal compound action potentials amplitude	27630
@NP	the strength	27630
@NP	maximal compound action potentials amplitude	27663
@NP	Donor cell labeling	27709
@NP	some experiments	27733
@NP	cells	27751
@NP	CFDA , SE -LRB- Molecular Probes , Eugene , OR -RRB-	27774
@NP	CFDA	27774
@NP	SE -LRB- Molecular Probes , Eugene , OR -RRB-	27780
@NP	SE	27780
@NP	Molecular Probes	27784
@NP	Eugene	27802
@NP	OR	27810
@NP	transplantation	27821
@NP	their location	27849
@NP	the time of killing	27867
@NP	the time	27867
@NP	killing	27879
@NP	cells or OECs	27908
@NP	20	27942
@NP	μM CFDA , SE for 15 min -LRB- ref	27945
@NP	μM CFDA	27945
@NP	SE for 15 min -LRB- ref	27954
@NP	SE for 15	27954
@NP	SE	27954
@NP	15	27961
@NP	min -LRB- ref	27964
@NP	27 -RRB- and washed 3 times with DMEM before transplantation .	27974
@NP	27	27974
@NP	3 times with DMEM	27989
@NP	3 times	27989
@NP	DMEM	28002
@NP	transplantation	28014
@NP	CFDA , SE loaded cells that were cultured for 2 --	28031
@NP	CFDA	28031
@NP	SE loaded cells	28037
@NP	SE	28037
@NP	loaded cells	28040
@NP	2	28076
@NP	4 weeks	28078
@NP	no evidence of dye toxicity and confirmed that the dye	28093
@NP	no evidence	28093
@NP	toxicity	28112
@NP	the	28140
@NP	Schwann cells and OECs	28164
@NP	the culture period	28198
@NP	Dye	28218
@NP	sensory neurons	28255
@NP	CFDA , SE loaded cells	28276
@NP	CFDA	28276
@NP	SE loaded cells	28282
@NP	SE	28282
@NP	loaded cells	28285
@NP	cultures of rat DRG neurons	28312
@NP	cultures	28312
@NP	rat DRG neurons	28324
@NP	Histology Following electrophysiological recordings , spinal cord tissue	28341
@NP	Histology	28341
@NP	electrophysiological recordings , spinal cord tissue	28361
@NP	electrophysiological recordings	28361
@NP	spinal cord tissue	28394
@NP	24 h	28427
@NP	2 % paraformaldehyde	28435
@NP	2 % glutaraldehyde -LRB- weight/volume in 0.14 M Sorensen 's buffer -RRB-	28460
@NP	2 % glutaraldehyde	28460
@NP	weight/volume in 0.14 M Sorensen 's buffer	28479
@NP	weight/volume	28479
@NP	0.14 M Sorensen 's buffer	28496
@NP	0.14 M	28496
@NP	Sorensen 's buffer	28503
@NP	Sorensen 's	28503
@NP	routine histological analysis	28526
@NP	4 % paraformaldehyde for confocal fluorescence microscopy	28560
@NP	4 % paraformaldehyde	28560
@NP	confocal fluorescence microscopy	28584
@NP	Tissue intended for routine histology	28618
@NP	Tissue	28618
@NP	routine histology	28638
@NP	3 times	28667
@NP	overnight in buffer	28683
@NP	overnight	28683
@NP	buffer	28696
@NP	2-mm segments	28716
@NP	Spinal cord segments	28731
@NP	1 % osmium -LRB- Polysciences , Warrington PA -RRB-	28778
@NP	1 % osmium	28778
@NP	Polysciences	28789
@NP	Warrington PA	28803
@NP	4 h	28822
@NP	Epox-812 -LRB- Ernest Fullam Inc. , Latham , NY -RRB-	28842
@NP	Epox-812	28842
@NP	Ernest Fullam Inc.	28852
@NP	Latham	28872
@NP	NY	28880
@NP	Tissue	28885
@NP	an ultramicrotome	28923
@NP	1-μm sections	28945
@NP	every 0.25 mm	28974
@NP	Sections	28989
@NP	0.5 % methylene blue , 0.5 % azure II	29028
@NP	0.5 % methylene blue	29028
@NP	0.5 % azure II	29049
@NP	0.5 % azure	29049
@NP	II	29060
@NP	0.5 % borax	29066
@NP	Spinal cords examined with confocal microscopy	29078
@NP	Spinal cords	29078
@NP	confocal microscopy	29105
@NP	PBS buffer	29145
@NP	1-cm lengths that were notched to indicate rostral/caudal orientation	29166
@NP	1-cm lengths	29166
@NP	rostral/caudal orientation	29209
@NP	three approximately equal longitudinal sections	29258
@VP	describe transplantation of olfactory ensheathing cells	133
@VP	expressing the human complement inhibitory protein , CD59 -LRB- hCD59 -RRB-	242
@VP	to induce axonal regeneration	393
@VP	induce axonal regeneration	396
@VP	receiving transgenic pig OECs or Schwann cells	544
@VP	was restored across and beyond the lesion site for more than a centimeter	610
@VP	restored across and beyond the lesion site for more than a centimeter	614
@VP	indicated that the donor cells migrated into the denervated host tract	699
@VP	migrated into the denervated host tract	730
@VP	denervated host tract	748
@VP	showed that the regenerated axons conducted impulses faster than normal axons	804
@VP	conducted impulses faster than normal axons	838
@VP	expected from the donor cell type	982
@VP	to reduce the hyperacute response in humans	1118
@VP	reduce the hyperacute response in humans	1121
@VP	induce elongative axonal regeneration and remyelination	1174
@VP	restore impulse conduction across the transected spinal cord	1234
@VP	are generally agreed to be an ethically acceptable source of cells	1466
@VP	agreed to be an ethically acceptable source of cells	1480
@VP	to be an ethically acceptable source of cells	1487
@VP	be an ethically acceptable source of cells	1490
@VP	can be collected for potential cell therapies	1585
@VP	be collected for potential cell therapies	1589
@VP	collected for potential cell therapies	1592
@VP	leads to complement-mediated cell lysis	1766
@VP	to address this problem	1820
@VP	address this problem	1823
@VP	to express a human complement inhibitory protein -LRB- e.g. , hCD59 -RRB-	1875
@VP	express a human complement inhibitory protein -LRB- e.g. , hCD59 -RRB-	1878
@VP	engineered to express hCD59	1996
@VP	to express hCD59	2007
@VP	express hCD59	2010
@VP	are transplanted into the transected rat spinal cord	2133
@VP	transplanted into the transected rat spinal cord	2137
@VP	form new myelin and restore conduction in the injured spinal cord	2224
@VP	form new myelin	2224
@VP	restore conduction in the injured spinal cord	2244
@VP	enhance axonal regeneration	2429
@VP	provide a rationale for their potential to enhance CNS axonal regeneration	2499
@VP	to enhance CNS axonal regeneration	2539
@VP	enhance CNS axonal regeneration	2542
@VP	can show Schwann cell or astrocyte-like cell properties6	2797
@VP	show Schwann cell or astrocyte-like cell properties6	2801
@VP	support CNS regeneration4 ,7	2910
@VP	to repair the transected3 -- 5 and demyelinated8 ,9 spinal cord	2981
@VP	repair the transected3 -- 5 and demyelinated8 ,9 spinal cord	2984
@VP	has been considered	3041
@VP	been considered	3045
@VP	considered	3050
@VP	attaining enough of the appropriate cells	3067
@VP	is still problematic	3109
@VP	expressing CD59	3600
@VP	was detected with the mAb PT85A and the goat antimouse	3639
@VP	detected with the mAb PT85A and the goat antimouse	3643
@VP	was used to determine background reactivity of a non-specific antibody	3712
@VP	used to determine background reactivity of a non-specific antibody	3716
@VP	to determine background reactivity of a non-specific antibody	3721
@VP	determine background reactivity of a non-specific antibody	3724
@VP	were analyzed on a Becton-Dickinson FACSort	3871
@VP	analyzed on a Becton-Dickinson FACSort	3876
@VP	showing transection site and positions of stimulating and recording electrodes	3985
@VP	stimulating and recording electrodes	4027
@VP	positioned 1 mm caudal to the dorsal column transection site -LRB- 0 mm -RRB-	4093
@VP	were obtained at 1 mm intervals beyond the lesion site	4176
@VP	obtained at 1 mm intervals beyond the lesion site	4181
@VP	are indicated by solid squares	4564
@VP	indicated by solid squares	4568
@VP	regenerated spinal cord axons	4651
@VP	, and transected following transplantation of transgenic OECs or Schwann cells	4790
@VP	, and transected	4790
@VP	and transected	4792
@VP	transected	4796
@VP	following transplantation of transgenic OECs or Schwann cells	4807
@VP	transected dorsal columns without cell transplantation , both OEC - and Schwann	4922
@VP	displayed conduction across the lesion for distances comparable to controls	5024
@VP	was similar between control and transplant groups	5290
@VP	labeled with the fluorescent membrane marker , CFDA	5425
@VP	were present in the dorsal columns 3 weeks after cell transplantation	5480
@VP	corresponds to 20 μm	5571
@VP	was fixed after in vitro	5732
@VP	fixed after in vitro	5736
@VP	were obtained	5789
@VP	obtained	5794
@VP	ascending sensory neurons	6100
@VP	are seen following Schwann cell transplantation	6236
@VP	seen following Schwann cell transplantation	6240
@VP	isolated from transgenic pigs expressing the human complement inhibitor , hCD59	6538
@VP	expressing the human complement inhibitor , hCD59	6568
@VP	were cultured as described in Experimental Protocol	6668
@VP	cultured as described in Experimental Protocol	6673
@VP	described in Experimental Protocol	6685
@VP	were analyzed by flow cytometry to assess transgene expression	6727
@VP	analyzed by flow cytometry to assess transgene expression	6732
@VP	to assess transgene expression	6759
@VP	assess transgene expression	6762
@VP	to detect endogenously expressed Swine Leukocyte Antigen -LRB- SLA -RRB- class I	6821
@VP	detect endogenously expressed Swine Leukocyte Antigen -LRB- SLA -RRB- class I	6824
@VP	expressed Swine Leukocyte Antigen -LRB- SLA -RRB- class I	6844
@VP	served as a positive control -LRB- Fig. 1 -RRB-	6896
@VP	isolated from the hCD59 transgenic pig -LRB- Fig. 1 -RRB-	7264
@VP	was very high in both cell types , however	7383
@VP	was an order of magnitude less in both the OECs and Schwann cells	7460
@VP	were anesthetized and laminectomies	7810
@VP	were performed to create the dorsal column lesion as described previously4	7846
@VP	performed to create the dorsal column lesion as described previously4	7851
@VP	to create the dorsal column lesion as described previously4	7861
@VP	create the dorsal column lesion as described previously4	7864
@VP	were randomly divided into two cohorts	7939
@VP	divided into two cohorts	7953
@VP	receiving either transgenic OECs or Schwann cells	8049
@VP	described in Experimental Protocol	8174
@VP	see Experimental Protocol	8368
@VP	was studied independently using anatomical techniques	8427
@VP	studied independently using anatomical techniques	8431
@VP	using anatomical techniques	8453
@VP	to have histologically complete transections of their dorsal columns	8536
@VP	have histologically complete transections of their dorsal columns	8539
@VP	were used for analysis	8605
@VP	used for analysis	8610
@VP	project within the fasciculus gracilis of the dorsal columns	8828
@VP	obtained across a lesion site with no cell transplantation	9336
@VP	were transplanted near the transection site	9430
@VP	transplanted near the transection site	9435
@VP	indicating axonal regeneration through the lesion site	9580
@VP	attenuated in amplitude as compared with non-transected control spinal cords	9756
@VP	was observed following transection alone	10238
@VP	observed following transection alone	10242
@VP	following transection alone	10251
@VP	indicate that the axons were myelinated as confirmed by histological analysis	10729
@VP	were myelinated as confirmed by histological analysis	10753
@VP	myelinated as confirmed by histological analysis	10758
@VP	confirmed by histological analysis	10772
@VP	transplanted dorsal columns	10985
@VP	are shown for control , OEC and Schwann cells transplantation in Figure 3B	11129
@VP	shown for control , OEC and Schwann cells transplantation in Figure 3B	11133
@VP	showed attenuation of the responses with increasing conduction distance	11234
@VP	is probably the result of temporal and spatial dispersion of the axons	11323
@VP	are not certain as to why this occurred	11587
@VP	occurred	11618
@VP	is reflected as greater stability of the response amplitude	11772
@VP	reflected as greater stability of the response amplitude	11775
@VP	assayed electrophysiologically	11884
@VP	occurred for a significant longitudinal distance within the spinal cord	11915
@VP	occurs through the discharge of several action potentials	12015
@VP	To determine if the regenerated axons could sustain high frequency discharge	12074
@VP	determine if the regenerated axons could sustain high frequency discharge	12077
@VP	could sustain high frequency discharge	12112
@VP	sustain high frequency discharge	12118
@VP	examined their frequency-response properties	12154
@VP	recorded 5 mm beyond the lesion site	12353
@VP	maintain stable high frequency discharge properties similar to normal axons	12530
@VP	were similar for all groups -LRB- Fig. 3D -RRB-	12696
@VP	see Experimental Protocol	12899
@VP	to demonstrate their survival and presence in the host	12926
@VP	demonstrate their survival and presence in the host	12929
@VP	not shown	13127
@VP	migrated several millimeters along the rostral-caudal axis of the spinal cord	13278
@VP	injected the donor cells into the margins of the transected cord both rostrally	13389
@VP	transected cord both rostrally	13438
@VP	were present in the spinal cord spanning the lesion gap	13568
@VP	spanning the lesion gap	13600
@VP	indicates that a ` bridge ' of donor cells was established	13624
@VP	was established	13665
@VP	established	13669
@VP	using standard plastic embedding protocols	13810
@VP	see Experimental Protocol	13854
@VP	used in this study	14118
@VP	were completely transected	14137
@VP	completely transected	14142
@VP	were slightly different between OEC and Schwann cell transplantation	14681
@VP	Myelinated axons in OEC transplanted lesions	14751
@VP	cell transplanted lesions seemed to be more random -LRB- Fig. 5B -RRB-	14953
@VP	seemed to be more random	14979
@VP	to be more random	14986
@VP	be more random	14989
@VP	established relatively thick myelin surrounded by a basement membrane	15122
@VP	surrounded by a basement membrane	15158
@VP	see Experimental Protocol	15390
@VP	myelinated axons within	15507
@VP	revealed an increase in the numbers of myelinated axons	15650
@VP	receiving transplants of transgenic pig OECs or Schwann cells	15755
@VP	transplanted with pig OECs or Schwann cells	15826
@VP	combined	16164
@VP	< 0.003 , respectively -LRB- unpaired two tailed Student 's t test -RRB-	16222
@VP	tailed Student 's t test	16258
@VP	-LRB- refs	16331
@VP	-LRB- refs	16365
@VP	remyelinate demyelinated axons	16401
@VP	facilitate axonal regeneration of transected axons in the rat spinal cord3	16443
@VP	thus suggesting the feasibility of xenotransplantation to repair axons	16642
@VP	to repair axons	16697
@VP	repair axons	16700
@VP	had received cell transplants	17146
@VP	received cell transplants	17150
@VP	crossing the lesion	17265
@VP	were indicative of myelinated axons	17285
@VP	was observed beyond the transection site	17586
@VP	observed beyond the transection site	17590
@VP	was similar to experiments using rat donor cells4	17751
@VP	using rat donor cells4	17778
@VP	does not reduce the repair potential of the cells in immunosuppressed rats	17881
@VP	reduce the repair potential of the cells in immunosuppressed rats	17890
@VP	were consistent with functionally remyelinated axons	17996
@VP	had conduction velocities greater than control	18136
@VP	to control axons	18192
@VP	control axons	18195
@VP	were also able to follow repetitive stimuli at frequencies up to 200 Hz	18228
@VP	to follow repetitive stimuli at frequencies up to 200 Hz	18243
@VP	follow repetitive stimuli at frequencies up to 200 Hz	18246
@VP	Taken together	18301
@VP	transected dorsal column lesion	18474
@VP	surrounding the myelin	18677
@VP	are characteristic	18743
@VP	is characteristic of peripheral myelin forming cells	18837
@VP	forming cells	18876
@VP	was observed in the spinal cord	18891
@VP	observed in the spinal cord	18895
@VP	to cluster in bundles	18982
@VP	cluster in bundles	18985
@VP	were more dispersed following Schwann cell transplantation	19030
@VP	was typical in the OEC transplants	19276
@VP	was contiguous	19717
@VP	regenerating axons and transplanted cells	19741
@VP	were present in the transition zone and beyond	19783
@VP	was indeed free of normal oligodendrocytemyelinated axons	19847
@VP	scattered regenerated axons that exhibited a peripheral pattern of myelination	19919
@VP	exhibited a peripheral pattern of myelination	19952
@VP	were completely transected by several cuts	20018
@VP	transected by several cuts	20034
@VP	would be virtually impossible	20121
@VP	be virtually impossible	20127
@VP	to explain the fusion of the cut spinal cord after the severe injury	20165
@VP	explain the fusion of the cut spinal cord after the severe injury	20168
@VP	may have migrated into the lesion zone	20269
@VP	have migrated into the lesion zone	20273
@VP	migrated into the lesion zone	20278
@VP	served as guide cells for the axons to extent across the lesion	20312
@VP	providing a hospitable regenerative environment	20379
@VP	induce growth cone collapse as do oligodendrocytes	20480
@VP	do oligodendrocytes	20511
@VP	have been neutralized by antibodies18	20645
@VP	been neutralized by antibodies18	20650
@VP	neutralized by antibodies18	20655
@VP	encourage axonal regeneration	20762
@VP	can express NGF P75 receptors and Schwann cells	20840
@VP	express NGF P75 receptors and Schwann cells	20844
@VP	are known to express NGF -LRB- ref	20888
@VP	known to express NGF -LRB- ref	20892
@VP	to express NGF -LRB- ref	20898
@VP	express NGF -LRB- ref	20901
@VP	-RRB- after axotomy	20921
@VP	to be determined	20948
@VP	be determined	20951
@VP	determined	20954
@VP	derived from hCD59 transgenic pigs	21172
@VP	can elicit axonal regeneration of functionally intact axons	21207
@VP	elicit axonal regeneration of functionally intact axons	21211
@VP	using engineered xenogeneic cells to repair damaged CNS axonal tracts	21319
@VP	to repair damaged CNS axonal tracts	21353
@VP	repair damaged CNS axonal tracts	21356
@VP	results in transection of axons	21428
@VP	can also result in demyelination of long tracts	21465
@VP	result in demyelination of long tracts	21474
@VP	can be observed in early several sclerosis lesions 22	21573
@VP	be observed in early several sclerosis lesions 22	21577
@VP	observed in early several sclerosis lesions 22	21580
@VP	can encourage at least some degree of axonal regeneration and form myelin	21705
@VP	encourage at least some degree of axonal regeneration and form myelin	21709
@VP	can be collected ethically in large numbers	21792
@VP	be collected ethically in large numbers	21796
@VP	collected ethically in large numbers	21799
@VP	approaches to repair the demyelinated or injured spinal cord	21888
@VP	to repair the demyelinated or injured spinal cord	21899
@VP	repair the demyelinated or injured spinal cord	21902
@VP	demyelinated or injured spinal cord	21913
@VP	are several clinical applications for the use of porcine tissues	21967
@VP	lead in many cases to loss of function and rejection of the transplanted tissue	22334
@VP	-LRB- ref	22535
@VP	would be expected to trigger a humoral and cellular immune response2	22568
@VP	be expected to trigger a humoral and cellular immune response2	22574
@VP	expected to trigger a humoral and cellular immune response2	22577
@VP	to trigger a humoral and cellular immune response2	22586
@VP	trigger a humoral and cellular immune response2	22589
@VP	perform comparable to allotransplants4	22715
@VP	have been modified to resist humoral immunity	22786
@VP	been modified to resist humoral immunity	22791
@VP	modified to resist humoral immunity	22796
@VP	to resist humoral immunity	22805
@VP	resist humoral immunity	22808
@VP	enforces the use of transgenic porcine tissues for human therapy	22833
@VP	obtained	23035
@VP	were removed and cut into 1-mm pieces	23230
@VP	removed and cut into 1-mm pieces	23235
@VP	was then centrifuged	23481
@VP	then centrifuged	23485
@VP	for OEC collections -RRB-	23625
@VP	then centrifuged	23669
@VP	modified Eagle 's medium -LRB- DMEM -RRB- with 10 %	23716
@VP	triturated through a flame polished siliconized pipette	23777
@VP	siliconized pipette	23813
@VP	was blocked with 10 % fetal calf serum containing medium	24033
@VP	blocked with 10 % fetal calf serum containing medium	24037
@VP	containing medium	24071
@VP	were washed twice in DMEM before resuspending them at 30,000 cells/μl in DMEM	24103
@VP	washed twice in DMEM before resuspending them at 30,000 cells/μl in DMEM	24108
@VP	resuspending them at 30,000 cells/μl in DMEM	24136
@VP	isolated from hCD59 transgenic animals	24235
@VP	served as a positive control antibody	24628
@VP	were used to detect specific antibody binding to the cell surface	25018
@VP	used to detect specific antibody binding to the cell surface	25023
@VP	to detect specific antibody binding to the cell surface	25028
@VP	detect specific antibody binding to the cell surface	25031
@VP	was then measured by flow cytometry on a Becton-Dickinson FACSort	25109
@VP	measured by flow cytometry on a Becton-Dickinson FACSort	25118
@VP	sparing the central vein	25628
@VP	subjected to the procedure	25723
@VP	did not prevent locomotion or impair eating , drinking or elimination	25755
@VP	prevent locomotion or impair eating , drinking or elimination	25763
@VP	prevent locomotion	25763
@VP	impair eating , drinking or elimination	25785
@VP	transplanted into each animal	26221
@VP	were killed under sodium pentobarbital anesthesia	26383
@VP	killed under sodium pentobarbital anesthesia	26388
@VP	removed and transferred	26515
@VP	saturated with 95 % O2/5 % CO2 at a drip rate of 4.0	26905
@VP	was then added to the solution	27013
@VP	added to the solution	27022
@VP	were obtained 2 h later at 36 °C	27077
@VP	obtained 2 h later at 36 °C	27082
@VP	running transversely across the dorsal surface of the spinal cord	27203
@VP	stimulating electrode	27287
@VP	was placed within the dorsal column 1 mm caudal to the transection site	27309
@VP	placed within the dorsal column 1 mm caudal to the transection site	27313
@VP	to elicit maximal compound action potentials amplitude	27653
@VP	elicit maximal compound action potentials amplitude	27656
@VP	to identify their location at the time of killing	27837
@VP	identify their location at the time of killing	27840
@VP	Dissociated Schwann cells or OECs	27888
@VP	were incubated with 20	27922
@VP	incubated with 20	27927
@VP	-RRB- and washed 3 times with DMEM before transplantation	27976
@VP	were cultured for 2	28058
@VP	cultured for 2	28063
@VP	dye toxicity and confirmed that the dye	28108
@VP	dye toxicity	28108
@VP	confirmed that the dye	28125
@VP	dye	28144
@VP	was retained in Schwann cells and OECs throughout the culture period	28148
@VP	retained in Schwann cells and OECs throughout the culture period	28152
@VP	were added to cultures of rat DRG neurons	28298
@VP	added to cultures of rat DRG neurons	28303
@VP	intended for routine histology	28625
@VP	was washed 3 times , stored overnight in buffer and cut into 2-mm segments	28656
@VP	was washed 3 times	28656
@VP	washed 3 times	28660
@VP	stored overnight in buffer	28676
@VP	cut into 2-mm segments	28707
@VP	post-fixed with 1 % osmium -LRB- Polysciences , Warrington PA -RRB- for 4 h	28762
@VP	embedded in Epox-812 -LRB- Ernest Fullam Inc. , Latham , NY -RRB-	28830
@VP	was then serially sectioned on an ultramicrotome	28892
@VP	serially sectioned on an ultramicrotome	28901
@VP	were collected every 0.25 mm	28959
@VP	collected every 0.25 mm	28964
@VP	counterstained with 0.5 % methylene blue , 0.5 % azure II in 0.5 % borax	29008
@VP	examined with confocal microscopy	29091
@VP	were transferred to PBS buffer	29125
@VP	transferred to PBS buffer	29130
@VP	cut into 1-cm lengths that were notched to indicate rostral/caudal orientation	29157
@VP	were notched to indicate rostral/caudal orientation	29184
@VP	notched to indicate rostral/caudal orientation	29189
@VP	to indicate rostral/caudal orientation	29197
@VP	indicate rostral/caudal orientation	29200
@VP	then sliced into three approximately equal longitudinal sections	29241
